These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38935685)

  • 1. Molecular characterization of HAMP rs10421768 gene and phenotypic expression of hepcidin; a case-control study among sickle cell anaemia patients in Ghana.
    Appiah SK; Nkansah C; Abbam G; Osei-Boakye F; Mensah K; Bani SB; Chemogo S; Sarpong L; Addae TG; Sefa DB; Croffien RA; Adom L; Rauf ROA; Boadu F; Amoah GA; Chukwurah EF
    PLoS One; 2024; 19(6):e0306194. PubMed ID: 38935685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of the HAMP (c.-582 A>G) Polymorphism in Iron Deficiency in Saudi Arabia.
    Al-Amer O; Alsharif KF
    Pak J Biol Sci; 2021 Jan; 24(1):146-150. PubMed ID: 33683041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Single-Nucleotide Polymorphism in the Hepcidin Promoter Gene with Susceptibility to Extrapulmonary Tuberculosis.
    Liang L; Liu H; Yue J; Liu LR; Han M; Luo LL; Zhao YL; Xiao H
    Genet Test Mol Biomarkers; 2017 Jun; 21(6):351-356. PubMed ID: 28530443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant.
    Parajes S; González-Quintela A; Campos J; Quinteiro C; Domínguez F; Loidi L
    BMC Genet; 2010 Dec; 11():110. PubMed ID: 21143959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy.
    Zarghamian P; Azarkeivan A; Arabkhazaeli A; Mardani A; Shahabi M
    BMC Med Genet; 2020 Apr; 21(1):75. PubMed ID: 32268883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients.
    Javaheri-Kermani M; Farazmandfar T; Ajami A; Yazdani Y
    Scand J Infect Dis; 2014 Oct; 46(10):693-6. PubMed ID: 25134646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence of Insomnia and the Link between Iron Metabolism Genes Polymorphisms,
    Skonieczna-Żydecka K; Jamioł-Milc D; Borecki K; Stachowska E; Zabielska P; Kamińska M; Karakiewicz B
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31936202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin (rs10421768), Transferrin (rs3811647, rs1049296) and Transferrin Receptor 2 (rs7385804) Gene Polymorphism Might Be Associated with the Origin of Multiple Sclerosis.
    Stachowska L; Koziarska D; Karakiewicz B; Kotwas A; Knyszyńska A; Folwarski M; Dec K; Stachowska E; Hawryłkowicz V; Kulaszyńska M; Sołek-Pastuszka J; Skonieczna-Żydecka K
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major.
    Andreani M; Radio FC; Testi M; De Bernardo C; Troiano M; Majore S; Bertucci P; Polchi P; Rosati R; Grammatico P
    Haematologica; 2009 Sep; 94(9):1293-6. PubMed ID: 19734422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.
    Olatunya OS; Albuquerque DM; Akanbi GO; Aduayi OS; Taiwo AB; Faboya OA; Kayode TS; Leonardo DP; Adekile A; Costa FF
    BMC Med Genet; 2019 Oct; 20(1):160. PubMed ID: 31619193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of iron regulating genes mutations on iron status in Egyptian patients with sickle cell disease.
    Abdel Rahman HA; Abou-Elew HH; El-Shorbagy RM; Fawzy R; Youssry I
    Ann Clin Lab Sci; 2014; 44(3):304-9. PubMed ID: 25117103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.
    Heinsberg LW; Arockiaraj AI; Crago EA; Ren D; Shaffer JR; Sherwood PR; Sereika SM; Weeks DE; Conley YP
    Neurocrit Care; 2020 Apr; 32(2):550-563. PubMed ID: 31346934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Komaki R; Hu Y; Hahn SM; Liao Z
    Cancer Med; 2018 Jun; 7(6):2247-2255. PubMed ID: 29745043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin and DNA promoter methylation in hepatocellular carcinoma.
    Udali S; Castagna A; Corbella M; Ruzzenente A; Moruzzi S; Mazzi F; Campagnaro T; De Santis D; Franceschi A; Pattini P; Gottardo R; Olivieri O; Perbellini L; Guglielmi A; Choi SW; Girelli D; Friso S
    Eur J Clin Invest; 2018 Feb; 48(2):e12870. PubMed ID: 29235098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle Cell and α+-Thalassemia Traits Influence the Association between Ferritin and Hepcidin in Rural Kenyan Children Aged 14-26 Months.
    Byrd KA; Williams TN; Lin A; Pickering AJ; Arnold BF; Arnold CD; Kiprotich M; Dentz HN; Njenga SM; Rao G; Colford JM; Null C; Stewart CP
    J Nutr; 2018 Dec; 148(12):1903-1910. PubMed ID: 30517728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.
    Fujiwara T; Ikeda T; Nagasaka Y; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Tomosugi N; Harigae H
    PLoS One; 2013; 8(9):e75568. PubMed ID: 24086573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hepatitis C virus NS5A and core proteins exert antagonistic effects on HAMP gene expression: the hidden interplay with the MTF-1/MRE pathway.
    Dimitriadis A; Foka P; Kyratzopoulou E; Karamichali E; Petroulia S; Tsitoura P; Kakkanas A; Eliadis P; Georgopoulou U; Mamalaki A
    FEBS Open Bio; 2021 Jan; 11(1):237-250. PubMed ID: 33247551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease.
    Huang YH; Kuo HC; Li SC; Cai XY; Liu SF; Kuo HC
    J Mol Cell Cardiol; 2018 Apr; 117():82-87. PubMed ID: 29501389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Correlation of HBB, HFE and HAMP Genes to Endocrinal Complications in Egyptian Beta Thalassemia Major Patients.
    Sokkar MF; Hamdy M; Taher MB; El-Sayed H; Bayomi EA; Amr KS; El-Kamah GY
    Biochem Genet; 2024 Jul; ():. PubMed ID: 38954212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of TMPRSS6 gene polymorphism with iron status in Egyptian children (a pilot study).
    Hamed HM; Bostany EE; Motawie AA; Abd Al-Aziz AM; Mourad AA; Salama HM; Kamel S; Hassan EM; Helmy NA; El-Saeed GS; Elghoroury EA
    BMC Pediatr; 2024 Feb; 24(1):105. PubMed ID: 38341535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.